Dean G. Tang
Affiliations: | The University of Texas Graduate School of Biomedical Sciences at Houston |
Area:
Cell Biology, OncologyGoogle:
"Dean Tang"Children
Sign in to add trainee
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Li F, Ling X, Chakraborty S, et al. (2023) Role of the DEAD-box RNA helicase DDX5 (p68) in cancer DNA repair, immune suppression, cancer metabolic control, virus infection promotion, and human microbiome (microbiota) negative influence. Journal of Experimental & Clinical Cancer Research : Cr. 42: 213 |
| Pencik J, Philippe C, Schlederer M, et al. (2023) STAT3/LKB1 controls metastatic prostate cancer by regulating mTORC1/CREB pathway. Molecular Cancer. 22: 133 |
| Kirk JS, Wang J, Tracz A, et al. (2023) Integrated single-cell analysis defines the epigenetic basis of castration-resistant prostate luminal cells. Biorxiv : the Preprint Server For Biology |
| Li WJ, Liu X, Dougherty EM, et al. (2022) MicroRNA-34a, Prostate Cancer Stem Cells, and Therapeutic Development. Cancers. 14 |
| Liu X, Li WJ, Puzanov I, et al. (2022) Prostate cancer as a dedifferentiated organ: androgen receptor, cancer stem cells, and cancer stemness. Essays in Biochemistry |
| Cable J, Pei D, Reid LM, et al. (2021) Cancer stem cells: advances in biology and clinical translation-a Keystone Symposia report. Annals of the New York Academy of Sciences |
| Tang DG. (2021) Understanding and targeting prostate cancer cell heterogeneity and plasticity. Seminars in Cancer Biology |
| Tang DG, Kondo T. (2021) Cancer cell heterogeneity and plasticity: From molecular understanding to therapeutic targeting. Seminars in Cancer Biology |
| Hu Q, Poulose N, Girmay S, et al. (2021) Inhibition of CDK9 activity compromises global splicing in prostate cancer cells. Rna Biology. 1-8 |
| Jamroze A, Chatta G, Tang DG. (2021) Androgen receptor (AR) heterogeneity in prostate cancer and therapy resistance. Cancer Letters |